These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 14552882)
1. Sensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson's disease in marmoset monkeys. Eslamboli A; Baker HF; Ridley RM; Annett LE Exp Neurol; 2003 Oct; 183(2):418-29. PubMed ID: 14552882 [TBL] [Abstract][Full Text] [Related]
2. Unilateral Intrastriatal 6-Hydroxydopamine Lesion in Mice: A Closer Look into Non-Motor Phenotype and Glial Response. Mendes-Pinheiro B; Soares-Cunha C; Marote A; Loureiro-Campos E; Campos J; Barata-Antunes S; Monteiro-Fernandes D; Santos D; Duarte-Silva S; Pinto L; José Salgado A Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768962 [TBL] [Abstract][Full Text] [Related]
3. Complex sensorimotor behavioral changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts. Rödter A; Winkler C; Samii M; Nikkhah G Cell Transplant; 2000; 9(2):197-214. PubMed ID: 10811393 [TBL] [Abstract][Full Text] [Related]
4. Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus). Eslamboli A; Cummings RM; Ridley RM; Baker HF; Muzyczka N; Burger C; Mandel RJ; Kirik D; Annett LE Exp Neurol; 2003 Nov; 184(1):536-48. PubMed ID: 14637123 [TBL] [Abstract][Full Text] [Related]
5. Pirouetting pigs: A large non-primate animal model based on unilateral 6-hydroxydopamine lesioning of the nigrostriatal pathway. Christensen AB; Sørensen JCH; Ettrup KS; Orlowski D; Bjarkam CR Brain Res Bull; 2018 May; 139():167-173. PubMed ID: 29462643 [TBL] [Abstract][Full Text] [Related]
6. Comparison of unilateral and bilateral intrastriatal 6-hydroxydopamine-induced axon terminal lesions: evidence for interhemispheric functional coupling of the two nigrostriatal pathways. Roedter A; Winkler C; Samii M; Walter GF; Brandis A; Nikkhah G J Comp Neurol; 2001 Apr; 432(2):217-29. PubMed ID: 11241387 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889 [TBL] [Abstract][Full Text] [Related]
8. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Iancu R; Mohapel P; Brundin P; Paul G Behav Brain Res; 2005 Jul; 162(1):1-10. PubMed ID: 15922062 [TBL] [Abstract][Full Text] [Related]
9. The 6-OHDA mouse model of Parkinson's disease - Terminal striatal lesions provide a superior measure of neuronal loss and replacement than median forebrain bundle lesions. Bagga V; Dunnett SB; Fricker RA Behav Brain Res; 2015 Jul; 288():107-17. PubMed ID: 25841616 [TBL] [Abstract][Full Text] [Related]
10. Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys. Henderson JM; Stanic D; Tomas D; Patch J; Horne MK; Bourke D; Finkelstein DI Behav Brain Res; 2005 May; 160(2):267-76. PubMed ID: 15863223 [TBL] [Abstract][Full Text] [Related]
11. Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. Eslamboli A; Georgievska B; Ridley RM; Baker HF; Muzyczka N; Burger C; Mandel RJ; Annett L; Kirik D J Neurosci; 2005 Jan; 25(4):769-77. PubMed ID: 15673656 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous intrastriatal 6-hydroxydopamine and quinolinic acid injection: a model of early-stage striatonigral degeneration. Ghorayeb I; Puschban Z; Fernagut PO; Scherfler C; Rouland R; Wenning GK; Tison F Exp Neurol; 2001 Jan; 167(1):133-47. PubMed ID: 11161601 [TBL] [Abstract][Full Text] [Related]
13. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Georgievska B; Kirik D; Björklund A Exp Neurol; 2002 Oct; 177(2):461-74. PubMed ID: 12429192 [TBL] [Abstract][Full Text] [Related]
14. Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats. Palmer MR; Granholm AC; van Horne CG; Giardina KE; Freund RK; Moorhead JW; Gerhardt GA Brain Res; 2001 Jan; 890(1):86-99. PubMed ID: 11164771 [TBL] [Abstract][Full Text] [Related]
15. Behavioral assessment of the effects of embryonic nigral grafts in marmosets with unilateral 6-OHDA lesions of the nigrostriatal pathway. Annett LE; Martel FL; Rogers DC; Ridley RM; Baker HF; Dunnett SB Exp Neurol; 1994 Feb; 125(2):228-46. PubMed ID: 7906227 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of dopaminergic drugs on spontaneous motor activity in the common marmoset following pretreatment with a bilateral brain infusion of 6-hydroxydopamine. Ando K; Nishime C; Inoue R; Nishinaka E; Kawai K; Urano K; Tsutsumi H Behav Pharmacol; 2017 Dec; 28(8):670-680. PubMed ID: 29099404 [TBL] [Abstract][Full Text] [Related]
17. Adeno-associated viral delivery of GDNF promotes recovery of dopaminergic phenotype following a unilateral 6-hydroxydopamine lesion. McGrath J; Lintz E; Hoffer BJ; Gerhardt GA; Quintero EM; Granholm AC Cell Transplant; 2002; 11(3):215-27. PubMed ID: 12075987 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence. Roghani M; Behzadi G Brain Res; 2001 Feb; 892(1):211-7. PubMed ID: 11172767 [TBL] [Abstract][Full Text] [Related]